Exhibit 23.3

               Consent of Ernst & Young LLP, Independent Auditors

     We consent to the reference to our firm under the caption "Experts" and to
the use of our report dated February 14, 2000, except with respect to Note 5, as
to which the date is April 26, 2000, with respect to the financial statements of
Kinetix Pharmaceuticals, Inc. (A Development-Stage Company), included in
Amendment No. 1 to Registration Statement (Form S-4, No. 333-49248) of Amgen
Inc. for the registration of 3,177,829 shares of its common stock.


                                 /s/  Ernst & Young LLP


Boston, Massachusetts
November 10, 2000